Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

RNAi therapeutic shows potential for AMD in animal model

March 8, 2005

Positive preliminary phase II data for Evizon in AMD

March 8, 2005

OccuLogix cleared to begin crossover studies of RHEO system for dry AMD

March 3, 2005

First patient treated in phase I advanced AMD study of Litx

March 1, 2005

GenVec expands testing of AdPEDF for AMD

Feb. 24, 2005

Enrollment targets met in two phase II studies of squalamine for AMD

Feb. 17, 2005

Phase III data on the effects of diquafosol ophthalmic solution in patients with dry eye

Feb. 15, 2005

Novartis inlicenses rebamipide for dry eye

Feb. 9, 2005

Phase III confirmatory study of Photrex planned

Feb. 4, 2005

Pharmos receives milestone for Zylet launch

Jan. 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...